Olanzapine exposure disordered lipid metabolism, gut microbiota and behavior in zebrafish (Danio rerio)

Yawei Wang1, Fu You1, Zhenyi Huang1

  • 1College of Fisheries, Henan Normal University, Xinxiang 453007, PR China.

Insights

Olanzapine (OLZ) exposure in zebrafish caused metabolic changes, including weight gain and altered lipid profiles, alongside behavioral deficits. Gut microbiota dysbiosis was linked to these olanzapine-induced effects.

Area of Science:

  • Environmental toxicology
  • Pharmacology
  • Zebrafish model systems

Background:

  • Olanzapine (OLZ) is a key antipsychotic for schizophrenia, but its metabolic side effects and mechanisms require further elucidation.
  • Understanding OLZ's impact is crucial for managing patient health and environmental safety.

Purpose of the Study:

  • To investigate the metabolic, behavioral, and gut microbiota alterations induced by OLZ exposure in zebrafish (Danio rerio).
  • To explore the underlying molecular mechanisms and correlations between microbiota changes and observed side effects.

Main Methods:

  • Zebrafish were exposed to varying concentrations of OLZ (35.5, 177.5, 355.5 μg/L).
  • Assessed body weight, lipid profiles (TC, LDL, TG), liver histology, gene expression (lipid metabolism, neurotransmitters), behavioral tests (motor activity, sociability, anxiety), and gut microbiota composition.
  • Performed correlation analysis between lipid metabolism, behavior, and microbiota.

Main Results:

  • OLZ exposure significantly increased body weight, total cholesterol, LDL, and triglycerides, with liver lipid accumulation.
  • Upregulation of lipid synthesis genes (srebp, acc, fas) and downregulation of lipid decomposition genes (lpl, hsl, cpt1b) were observed.
  • Reduced motor activity, sociability, and anxiety-like behaviors correlated with altered neurotransmitter gene expression (tph, th, dat, glsa, gad1b).
  • Gut microbiota diversity decreased, with notable shifts in Plesiomonas, Bacillus, and Cetobacterium abundance.
  • Lipid metabolism and behavioral changes were significantly associated with microbiota alterations.

Conclusions:

  • Olanzapine induces significant metabolic disturbances, behavioral changes, and gut dysbiosis in zebrafish, highlighting its multifaceted side effects.
  • The study provides insights into OLZ's mechanisms of action and establishes a basis for determining safe environmental discharge concentrations and clinical usage guidelines.